This is the second of two tables from the Meaningful Use Standards rule that I've prepared. The first table mapped the objectives to the criteria.
This table crosswalks from the old Stage 1 criteria to the Stage 2 criteria and the standards in Stage 2. The notes column combines information from several tables to tell you whether the criterion is Ambulatory or Inpatient (A or I), included in the definition of a Base EHR (B), requires clock synchronization using NTP (C), or must be implemented with User Centered design (U). New criteria are shown in bold. As before, when the regulation is published in the Federal Register, I'll link citations back to it on the Web, and when I get around to it, I'll add web links to the standards (until then, you can find most of the links you need here).
If you want the spreadsheet containing both of these tables, it's here. Feel free to use these pages or the spreadsheets for developing your own comments and in presentations (please cite your source).
| Stage 1 | Meaningful Use Stage 2 Cross Walk | |||||
| Amb. | Inpatient | Stage 2 | Notes | Certification Criteria | Standards | |
| 304(a) | 306(a) | 314(a)(1) | BU | Computerized provider order entry | ||
| 302(a) | 314(a)(2) | BCU | Drug-drug, drug-allergy interaction checks | |||
| 304(c) | 306(b) | 314(a)(3) | B | Demographics | 207(f) | OMB standards for the classification of federal data on race and ethnicity |
| 207(j) | ISO 639-1:2002 (preferred language) | |||||
| 207(k) | ICD-10-CM (preliminary cause of death) | |||||
| 302(f) | 314(a)(4) | B | Vital signs, body mass index, and growth charts | |||
| 302(c) | 314(a)(5) | B | Problem list | 207(a)(3) | SNOMED-CT® International Release January 2012 | |
| 302(d) | 314(a)(6) | BU | Medication list | |||
| 302(e) | 314(a)(7) | BU | Medication allergy list | |||
| 304(e) | 306(c) | 314(a)(8) | BCU | Clinical decision support | 204(b)(1) | HL7 Context-Aware Knowledge Retrieval (Infobutton) Standard, International Normative Edition 2010 |
| 314(a)(9) | Clinical Notes | |||||
| 302(b) | 314(a)(10) | C | Drug-formulary checks | |||
| 302(g) | 314(a)(11) | Smoking status | 207(l) | smoking status types | ||
| 314(a)(12) | Imaging | |||||
| 314(a)(13) | Family History | |||||
| 302(i) | 314(a)(14) | C | Patient lists | |||
| 304(d) | 314(a)(15) | A | Patient reminders | |||
| 302(m) | 314(a)(16) | Patient-specific education resources | 204(b)(1) | HL7 Context-Aware Knowledge Retrieval (Infobutton) Standard, International Normative Edition 2010 | ||
| 314(a)(17) | CIU | Medication Administration: Five Rights | 210(g) | Synchronized clocks | ||
| 306(h) | 314(a)(18) | I | Advance directives | |||
| 304(i) | 306(f) | 314(b)(1) 314(b)(2) | B | Transitions of care – incorporate/create summary care record | 205(a)(3) | Consolidated CDA |
| 207(f) | OMB standards for the classification of federal data on race and ethnicity | |||||
| 207(j) | ISO 639-1:2002 (preferred language) | |||||
| 207(l) | smoking status types | |||||
| 207(a)(3) | SNOMED-CT® International Release January 2012 | |||||
| 207(m) | ICD-10-CM | |||||
| 207(b)(2) | HCPCS and CPT-4 | |||||
| 207(b)(3) | ICD-10-PCS | |||||
| 207(g) | LOINC version 2.38 | |||||
| 207(h) | RxNorm February 6, 2012 Release | |||||
| 314(b)(2) | Transitions of care – transmit summary care record | 202(a)(1) | Applicability Statement for Secure Health Transport | |||
| 202(a)(2) | XDR and XDM for Direct Messaging | |||||
| 202(a)(3) | SOAP-Based Secure Transport RTM version 1.0 (Optional) | |||||
| 304(b) | 314(b)(3) | U | Electronic prescribing | 205(b)(2) | NCPDP SCRIPT version 10.6 | |
| 207(h) | RxNorm February 6, 2012 Release | |||||
| 302(j) | 314(b)(4) | U | Clinical information reconciliation | |||
| 302(h) | 314(b)(5) | A | Incorporate lab tests and values/results | 205(k) | HL7 2.5.1 and HL7 Version 2.5.1 Implementation Guide: Standards and Interoperability Framework Lab Results Interface, Release 1 (US Realm) | |
| 207(g) | LOINC version 2.38 | |||||
| §493.1291(c)(1-7) | CLIA | |||||
| 314(b)(6) | I | Transmit Lab Results | 205(k) | HL7 2.5.1 and HL7 Version 2.5.1 Implementation Guide: Standards and Interoperability Framework Lab Results Interface, Release 1 (US Realm) | ||
| 207(g) | LOINC version 2.38 | |||||
| 314(c)(1) | B | Clinical Quality Measures - Capture and Export | 204(c) | National Quality Forum (NQF) Quality Data Model (QDM) | ||
| 314(c)(2) | B | Clinical quality measures – incorporate and calculate | ||||
| 314(c)(3) | Clinical quality measures – reporting | "a data file defined by CMS" | ||||
| 302(o) | 314(d)(1) | B | Authentication, access control, and authorization | |||
| 302(t) | ||||||
| 314(d)(2) | B | Auditable events and tamper-resistance | ||||
| 302(r) | 314(d)(3) | B | Audit report(s) | |||
| 314(d)(4) | B | Amendments | ||||
| 302(q) | 314(d)(5) | B | Automatic log-off | |||
| 302(p) | 314(d)(6) | B | Emergency access | |||
| 302(u) | 314(d)(7) | B | Encryption of data at rest | 210(a)(1) | FIPS 140-2 Annex A for Encryption and Hashing | |
| 302(s) | 314(d)(8) | B | Integrity | 210(c) | FIPS PUB 180–3 (SHA-1) | |
| 302(w) | 314(d)(9) | Accounting of disclosures (optional) | 210(d) | date, time, patient identification, user identification, and a description of the disclosure | ||
| 304(g) | 314(e)(1) | B | View, download, and transmit to 3rd party | 204(a) | Web Content Accessibility Guidelines (WCAG) 2.0, Level AA Conformance | |
| 304(f) | 306(d) | 205(a)(3) | Consolidated CDA | |||
| 306(e) | 205(j) | DICOM PS 3—2011 | ||||
| 207(f) | OMB standards for the classification of federal data on race and ethnicity | |||||
| 207(j) | ISO 639-1:2002 (preferred language) | |||||
| 207(l) | smoking status types | |||||
| 207(a)(3) | SNOMED-CT® International Release January 2012 | |||||
| 207(m) | ICD-10-CM | |||||
| 207(b)(2) | HCPCS and CPT-4 | |||||
| 207(b)(3) | ICD-10-PCS | |||||
| 207(g) | LOINC version 2.38 | |||||
| 207(h) | RxNorm February 6, 2012 Release | |||||
| 202(a)(1) | Applicability Statement for Secure Health Transport | |||||
| 202(a)(2) | XDR and XDM for Direct Messaging | |||||
| 210(g) | Synchronized clocks | |||||
| 304(h) | 314(e)(2) | A | Clinical Summaries | |||
| 314(e)(3) | A | Secure Messaging | 210(f) | FIPS 140-2 Annex A for Encryption and Hashing | ||
| 302(k) | 314(f)(1) | Record, Change and access Immunization information | ||||
| 314(f)(2) | C | Transmission to immunization registries | 205(e)(3) | HL7 2.5.1 and Implementation Guide for Immunization Messaging Release 1.3 | ||
| 207(i) | CVX code set: August 15, 2011 version | |||||
| 302(l) | 314(f)(3) | Record, Change and access surveillance information | ||||
| 314(f)(4) | C | Transmission to PH agencies | 205(d)(2) | HL7 2.5.1 | ||
| 205(d)(3) | HL7 2.5.1 and the PHIN Messaging Guide for Syndromic Surveillance: Emergency Department and Urgent Care Data HL7 Version 2.5.1 | |||||
| 306(g) | 314(f)(5) | Reportable lab tests and values/results | ||||
| 314(f)(6) | C | Transmission of reportable lab tests and values/results | 205(g) | HL7 2.5.1 and HL7 Version 2.5.1 Implementation Guide: Electronic Laboratory Reporting to Public Health, Release 1 (US Realm) with errata | ||
| 207(a)(3) | SNOMED CT® International Release January 2012 | |||||
| 207(g) | LOINC version 2.38 | |||||
| 314(f)(7) | Record, Change and Access Cancer Information | |||||
| 314(f)(8) | C | Transmission to Cancer Registries | 205(i) | HL7 CDA, Release 2 and Implementation Guide for Healthcare Provider Reporting to Central Cancer Registries, Draft, February 2012 | ||
| 207(a)(3) | SNOMED CT® International Release January 2012 | |||||
| 207(g) | LOINC version 2.38 | |||||
| 314(g)(1) | Automated numerator recording | |||||
| 302(n) | 314(g)(2) | Automated measure calculation | ||||
| 314(g)(3) | Non-percentage-based measure use report | 210(g) | Synchronized clocks | |||
| 314(g)(4) | Safety-enhanced design | |||||
Off-topic, but see this blog post by Peter Pronovost, which would seem to have a great deal to do with HL7's overall mission, ever since its inception. Perhaps it's worth a post on your blog at some point.
ReplyDeleteAlso, in connection with InfoButton and CDS generally, see his subsequent post.
Your generosity in sharing this infomraiton means so much. Thanks a million.
ReplyDelete